NATIONAL MULTICENTER, CONTROLLED, SINGLE-BLIND STUDY WITH TWO PARALLEL GROUPS EVALUATING THE SAFETY AND EFFICACY OF SEQUENTIAL TREATMENT WITH MITOXANTRONE AND INTERFERON VERSUS INTERFERON ALONE IN PATIENTS WITH STRONG RISK OF PROGRESSION IN THE INITIAL PHASE OF MULTIPLE SCLEROSIS: